Supplemental material
OncoImmunology
Volume 6, 2017 - Issue 12
Open access
3,799
Views
87
CrossRef citations to date
0
Altmetric
Original Research
Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles
Vanesa G. MartinezSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
, Sadhbh O'NeillSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
, Josephine SalimuInstitute of Cancer and Genetics, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, Wales
, Susan BreslinSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
, Aled ClaytonInstitute of Cancer and Genetics, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, Wales
, John CrownDepartment of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland
& Lorraine O'DriscollSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, IrelandCorrespondence[email protected]
show all
Article: e1362530
|
Received 22 Jun 2017, Accepted 28 Jul 2017, Published online: 14 Sep 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.